Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Multiple sclerosis enters a grey area

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Nature 566, 465-466 (2019)



  1. The International Multiple Sclerosis Genetics Consortium. Nature 476, 214–219 (2011).

    Article  PubMed  Google Scholar 

  2. Lodygin, D. et al. Nature 566, 503–508 (2019).

    Article  Google Scholar 

  3. Stern, J. N. et al. Sci. Transl. Med. 6, 248ra107248ra107 (2014).

    Article  Google Scholar 

  4. Dendrou, C. A., Fugger, L. & Friese, M. A. Nature Rev. Immunol. 15, 545–558 (2015).

    Article  PubMed  Google Scholar 

  5. Ota, K. et al. Nature 346, 183–187 (1990).

    Article  PubMed  Google Scholar 

  6. Cao, Y. et al. Sci. Transl. Med. 7, 287ra74 (2015).

    Article  PubMed  Google Scholar 

  7. Jelcic, I. et al. Cell 175, 85–100 (2018).

    Article  PubMed  Google Scholar 

  8. Lucchinetti, C. F. et al. N. Engl. J. Med. 365, 2188–2197 (2011).

    Article  PubMed  Google Scholar 

  9. Calabrese, M. et al. Brain 135, 2952–2961 (2012).

    Article  PubMed  Google Scholar 

  10. Brown, J. W. L. et al. J. Am. Med. Assoc. 321, 175–187 (2019).

    Article  Google Scholar 

  11. Mor, F., Quintana, F., Mimran, A. & Cohen, I. R. J. Immunol. 170, 628–634 (2003).

    Article  PubMed  Google Scholar 

  12. Sulzer, D. et al. Nature 546, 656–661 (2017).

    Article  PubMed  Google Scholar 

  13. Vargas, K. J. et al. J. Neurosci. 34, 9364–9376 (2014).

    Article  PubMed  Google Scholar 

Download references

Competing Interests

D.A.H. has received funding from Bristol-Myers Squibb, Novartis and Genentech. D.A.H. has been a consultant for Compass Therapeutics, EMD Serono, Novartis Pharmaceuticals, Sanofi Genzyme and Versant Venture, Genentech and Proclara Bioscience.


Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links